A more detailed understanding about the role of CAMKK2 in activation of the tyrosine phosphoproteome and, in particular, PTK2/JUN/STAT3 signaling in gastric cancer is needed, in addition to functional studies in preclinical models, which is beyond the scope of this article. This evidence concerns the gene JUN and gastric cancer.